Two individual genes of module 6 were associated with treatment response, with IL18R1 being associated with good treatment response and IL1RAP being associated with poor response, in agreement with previous biological understanding of the IL18 and IL1 axes in cancer therapy33–35. This evidence concerns the gene IL18 and cancer.